Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Clin Nutr ; 43(6): 1372-1383, 2024 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-38678822

RESUMO

BACKGROUND & AIMS: Sepsis-induced disseminated intravascular coagulation (DIC) is characterised by abnormal blood clotting resulting from severe infection, contributing to organ dysfunction in sepsis. Resolvin D1 (RvD1) is an endogenous lipid mediator, synthesised from the omega-3 polyunsaturated fatty acid (PUFA) docosahexaenoic acid (DHA) through enzymatic processes involving 15-LOX and 5-LOX. RvD1 is recognised for its protective properties against various inflammatory conditions. This study aims to investigate its potential to modulate coagulation dysfunction in sepsis and to evaluate coagulation disorders in septic patients. METHODS: Sepsis models were established by intraperitoneal injection LPS (20 mg/kg) or cecal ligation and puncture (CLP) followed by injection of RvD1 (10 µg/kg) or saline. The impact of RvD1 on coagulation dysfunction was assessed by clotting time and coagulation indicators such as TAT, D-dimer, PAI-1, and fibrinogen. The activity of the coagulation system in vivo was observed by evaluating dynamic microcirculation, platelets and thrombin in mice using intravital microscopy. The effect of RvD1 on pyroptosis was investigated by measuring NOD-like receptor protein 3 (NLRP3), Caspase-1, Caspase-11, and Gasdermin D (GSDMD) levels via western blot. Caspase-1 knockout mice, GSDMD knockout mice and bone marrow-derived macrophages (BMDMs) were used to elucidate the underlying mechanisms. Lastly, the concentration of RvD1 in plasma from septic patients was quantified to explore its relationship with coagulation and pyroptosis. RESULTS: RvD1 significantly attenuated coagulation dysfunction in septic mice induced by LPS and CLP, and inhibited Caspase-1/GSDMD-dependent pyroptosis in septic mice and bone marrow-derived macrophages. In septic patients, the plasma concentrations of RvD1 was negatively correlated with both coagulation-related indicators and markers of GSDMD activation. CONCLUSION: The results suggest that RvD1 can improve coagulation dysfunction in sepsis by regulating the Caspase-1/GSDMD pyroptotic pathway. Additionally, the concentration of RvD1 in septic patient plasma is related to prognosis and DIC development. RvD1 could be a potential biomarker and a promising therapeutic alternative in sepsis-induced DIC.


Assuntos
Caspase 1 , Coagulação Intravascular Disseminada , Ácidos Docosa-Hexaenoicos , Camundongos Endogâmicos C57BL , Proteínas de Ligação a Fosfato , Piroptose , Sepse , Animais , Sepse/complicações , Sepse/tratamento farmacológico , Coagulação Intravascular Disseminada/tratamento farmacológico , Coagulação Intravascular Disseminada/etiologia , Camundongos , Masculino , Caspase 1/metabolismo , Humanos , Ácidos Docosa-Hexaenoicos/farmacologia , Piroptose/efeitos dos fármacos , Proteínas de Ligação a Fosfato/metabolismo , Peptídeos e Proteínas de Sinalização Intracelular/metabolismo , Modelos Animais de Doenças , Feminino , Pessoa de Meia-Idade , Camundongos Knockout , Transdução de Sinais/efeitos dos fármacos , Idoso , Gasderminas
2.
Sci Rep ; 11(1): 13032, 2021 06 22.
Artigo em Inglês | MEDLINE | ID: mdl-34158566

RESUMO

Osteoarthritis (OA) is the most prevalent joint disease and is one of the major causes of disability in the world. There has been an increase in the incidence of OA, which is associated with an aging population, sedentary lifestyle, and reduced physical activity. Due to the complex OA pathogenesis, there are limited diagnostic tools. OA is a degenerative joint disorder with a recognized inflammatory component, usually described as abnormal expression of inflammatory factors. For instance, interleukin 6 (IL-6) has been shown to be upregulated in serum and synovial fluid among patients with OA. Most of the inflammatory factors have been associated with the expression of long noncoding RNAs (lncRNAs). However, the role of the novel lncRNA Fer-1-like protein 4 (FER1L4) in OA is yet to be determined. Here, we interrogated the expression profile of FER1L4 in patients with OA to define its potential application as a diagnostic marker. We collected synovial fluid and blood samples from both OA cases and normal controls. Using qRT-PCR, we evaluated the expression of FER1L4 in plasma and synovial fluid. On the other hand, the expression of IL-6 in plasma and synovial fluid was assessed using ELISA. Besides, the effect of age, gender or disease stage in the expression of the FER1L4 in plasma was also estimated. Moreover, the receiver operating characteristic (ROC) curves were used to determine the impact of FER1L4 in OA cases compared with the normal controls. In addition, we analyzed the correlation between FER1L4 and IL-6 through Pearson correlation analysis. Also, IL-6 expression in overexpressed FER1L4 samples was detected in chondrocytes through western blot analysis, while FER1L4 expression following endogenous IL-6 exposure was detected by qRT-PCR. Our data showed that whereas lncRNA FER1L4 is downregulated in OA patients, IL-6 is upregulated. The plasma FER1L4 levels among the OA cases were suppressed with disease progression and old age, and the down-regulation could efficiently discriminate OA patients from normal subjects. In addition, upregulation of FER1L4 inhibited IL-6 expression in human chondrocyte cells, and treatment with different concentrations of exogenous IL-6 did not affect the expression of FER1L4. Taken together, our data demonstrates that FER1L4 could efficiently identify OA cases from normal subjects, and can also modulate the expression of IL-6 in human chondrocytes.


Assuntos
Condrócitos/metabolismo , Condrócitos/patologia , Regulação da Expressão Gênica , Interleucina-6/genética , Osteoartrite/genética , RNA Longo não Codificante/genética , Adulto , Idoso , Envelhecimento/genética , Estudos de Casos e Controles , Progressão da Doença , Feminino , Humanos , Interleucina-6/metabolismo , Masculino , Pessoa de Meia-Idade , Osteoartrite/sangue , RNA Longo não Codificante/sangue , RNA Longo não Codificante/metabolismo , Líquido Sinovial/metabolismo
3.
Biochem Biophys Res Commun ; 521(3): 786-790, 2020 01 15.
Artigo em Inglês | MEDLINE | ID: mdl-31706571

RESUMO

Hydrogen sulfide (H2S) is a novel adipokine mediating glucose uptake, lipid storage and mobilization, thus contributing to the genesis of obesity and associated diseases. Our previous work demonstrated that H2S inhibited isoproterenol-stimulated lipolysis by reducing the phosphorylation of perilipin 1 (plin-1), a lipid-droplet protein blocking lipase access. How H2S modulates plin-1 phosphorylation is still unclear. Our present study found that an H2S donor slightly increased adipose tissue weight and reduced lipolysis in mice; by contrast, deleting the key H2S generation enzyme cystathionine gamma lyase (CSE) in adipocytes lowered adipose accumulation and enhanced lipolysis. Intriguingly, an H2S donor induced sulfhydration of plin-1 but not hormone-sensitive lipase, and CSE deletion abolished the post-translational modification of plin-1. During isoproterenol-stimulated lipolysis, plin-1 sulfhydration was associated with reduced phosphorylation, and removing sulfhydration by dithiothreitol recovered the phosphorylation. Finally, plin-1 knockout abolished the effect of H2S on lipolysis, which indicates that plin-1 sulfhydration is a major direct target of H2S in lipolysis. We have identified a new post-translation modification, sulfhydration (direct action by H2S) of plin-1, causing reduced phosphorylation then decreased lipolysis. This finding also highlights a novel molecular regulatory mechanism of lipolysis.


Assuntos
Adipócitos/metabolismo , Cistationina gama-Liase/metabolismo , Sulfeto de Hidrogênio/metabolismo , Lipólise , Perilipina-1/metabolismo , Animais , Células Cultivadas , Masculino , Camundongos Endogâmicos C57BL , Fosforilação , Processamento de Proteína Pós-Traducional , Ratos Sprague-Dawley
4.
Ultrasonics ; 53(1): 171-7, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22901395

RESUMO

The control problem in ultrasound therapy is to destroy the tumor tissue while not harming the intervening healthy tissue with a desired temperature elevation. The objective of this research is to present a robust and feasible method to control the temperature distribution and the temperature elevation in treatment region within the prescribed time, which can improve the curative effect and decrease the treatment time for heating large tumor (≥2.0cm in diameter). An adaptive self-tuning-regulator (STR) controller has been introduced into this control method by adding a time factor with a recursive algorithm, and the speed of sound and absorption coefficient of the medium is considered as a function of temperature during heating. The presented control method is tested for a self-focused concave spherical transducer (0.5MHz, 9cm aperture, 8.0cm focal length) through numerical simulations with three control temperatures of 43°C, 50°C and 55°C. The results suggest that this control system has adaptive ability for variable parameters and has a rapid response to the temperature and acoustic power output in the prescribed time for the hyperthermia interest. There is no overshoot during temperature elevation and no oscillation after reaching the desired temperatures. It is found that the same results can be obtained for different frequencies and temperature elevations. This method can obtain an ellipsoid-shaped ablation region, which is meaningful for the treatment of large tumor.


Assuntos
Hipertermia Induzida/instrumentação , Temperatura , Terapia por Ultrassom/instrumentação , Algoritmos , Simulação por Computador , Humanos , Neoplasias/terapia , Transdutores
5.
Ultrasonics ; 50(6): 628-33, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20156630

RESUMO

Temperature control of hyperthermia treatments is generally implemented with multipoint feedback system comprised of phased-array transducer, which is complicated and high cost. Our simulations to the acoustic field induced by a self-focused concave spherical transducer (0.5MHz, 9cm aperture width, 8.0cm focal length) show that the distribution of temperature can keep the same "cigar shape" in the focal region during ultrasound insonation. Based on the characteristic of the temperature change, a two-dimensional model of a "cigar shape" tumor is designed and tested through numerical simulation. One single-point on the border of the "cigar shape" tumor is selected as the control target and is controlled at the temperature of 43 degrees C by using a self-tuning regulator (STR). Considering the nonlinear effects of biological medium, an accurate state-space model obtained via the finite Fourier integral transformation to the bioheat equation is presented and used for calculating temperature. Computer simulations were performed with the perfusion rates of 2.0kg/(m(3)s) and 4.5kg/(m(3)s) to the different targets, it was found that the temperatures on the border of the "cigar shape" tumor can achieve the desired temperature of 43 degrees C by control of one single-point. A larger perfusion rate requires a higher power output to obtain the same temperature elevation under the same insonation time and needs a higher cost for compensating the energy loss carried away by blood flow after steady state. The power output increases with the controlled region while achieving the same temperature at the same time. Especially, there is no overshoot during temperature elevation and no oscillation after steady state. The simulation results demonstrate that the proposed approach may offers a way for obtaining a single-point, low-cost hyperthermia system.


Assuntos
Hipertermia Induzida/métodos , Temperatura , Transdutores , Simulação por Computador , Análise de Fourier , Humanos , Neoplasias/terapia , Terapia por Ultrassom/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA